1 Introduction Recent advances in immunotherapy have demonstrated the potential of targeting the tumour immune microenvironment (TIME), with evidence of improved clinical outcomes for patients [1, 2]. TIME varies from individual to individual and is closely associated with patient prognosis.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile